The usefulness of determining des-γ-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma

Cancer

Volumn 82, Issue 9, 1998, Pages 1643-1648

  Mita, Yuhsaku ^a   Aoyagi, Yutaka ^a   Yanagi, Masahiko ^a   Suda, Takeshi ^a   Suzuki, Yasufumi ^a   Asakura, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Des carboxy prothrombin; Early diagnosis; Enzyme immunoassay; Hepatocellular carcinoma; fetoprotein

Indexed keywords

DECARBOXYPROTHROMBIN;

ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0032080912     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980501)82:9<1643::AID-CNCR8>3.0.CO;2-B     Document Type: Article

References (26)

1. Okuda K and the Liver Cancer Group of Japan. Primary liver cancer in Japan. Cancer 1980;45:2663-9.
2. Abelev GI. Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data. Cancer Res 1968;28:1344-50.
3. O'Conor GI, Tatarinov YS, Abelev GI, Uriel J. A collaborative study for the evaluation of a serologic test for primary liver cancer. Cancer 1970;25:1091-8.
4. Nishi S, Hirai H. Radioimmunoassay of alpha-fetoprotein in hepatoma, other liver diseases and pregnancy. Gann Monogr 1973;14:79-87.
5. Liebman H, Furie BC, Tong MJ, Blanchard RA, Lo K-J, Lee S-D, et al. Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984;310:1427-31.
6. Okuda H, Obata H, Nakanishi T, Furukawa R, Hashimoto E. Production of abnormal prothrombin (des-γ-carboxy prothrombin) by hepatocellular carcinoma: a clinical and experimental study. J Hepatol 1987;4:357-63.
7. Fujiyama S, Morishita T, Hashiguchi O, Sato T. Plasma abnormal prothrombin (des-γ-carboxy prothrombin) as a marker of hepatocellular carcinoma. Cancer 1988;61:1621-8.
8. Hattori N, Ohmizo R, Unoura M, Tanaka N, Kobayashi K, and the PIVKA-II collaborative working group. Abnormal prothrombin measurements in hepatocellular carcinoma. J Tumor Marker Oncol 1988;3:207-16.
9. Yumoto Y, Jinno K, Tokuyama K, Ishimitsu T, Maeda H, Konno T, et al. Hepatocellular carcinoma detected by iodized oil. Radiology 1985;154:19-24.
10. Schwerk WB, Schmitz-Moormann P. Ultrasonically guided fine-needle biopsies in neoplastic liver diseases: cytohistologic diagnosis and echo pattern of lesions. Cancer 1981;48:1469-77.
11. Noguchi S, Yamamoto R, Tatsuta M, Kasugai H, Okuda S, Wada A, et al. Cell features and patterns in fine-needle aspirate of hepatocellular carcinoma. Cancer 1986;58:321-8.
12. Majima Y, Fujimoto T, Iwai I, Tanaka M, Abe M, Abe H, et al. Histological diagnosis of hepatocellular carcinoma by a new technique of ultrasound-guided fine-needle biopsy [in Japanese]. Acta Hepatol Jpn 1988;29:628-36.
13. Shinagawa T, Ohto M, Kimura K, Tsunetomi S, Morita M, Saisho H, et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of realtime ultrasonography: a study in 51 patients. Gastroenterology 1984;86:495-502.
14. Karvountzis GG, Redeker AG. Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis. Intern Med 1974;80:156-60.
15. Chen D-S, Sung J-L. Serum alpha-fetoprotein in hepatocellular carcinoma. Cancer 1977;40:779-83.
16. Alpert E, Feller ER. Alpha-fetoprotein (AFP) in benign liver diseases: evidence that normal liver regeneration does not induce AFP synthesis. Gastroenterology 1978;74:856-8.
17. Aoyagi Y, Suzuki Y, Isemura M, Soga K, Ozaki T, Ichida T, et al. Differential reactivity of alpha-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma. Gann 1984;75:809-15.
18. Aoyagi Y, Suzuki Y, Isemura M, Nomoto M, Sekine C, Igarashi K, et al. The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer 1988;61:769-74.
19. Aoyagi Y, Isemura M, Suzuki Y, Sekine C, Soga K, Ozaki T, et al. Fucosylated alpha-fetoprotein as marker of early hepatocellular carcinoma. Lancet 1985;ii:1353-4.
20. Taketa K, Sekiya C, Namiki M, Akamatsu K, Ohta Y, Endo Y, et al. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology 1990;99:508-18.
21. Aoyagi Y, Isemura M, Yosizawa Z, Suzuki Y, Sekine C, Ono T, et al. Fucosylation of serum alpha-fetoprotein with primary hepatocellular carcinoma. Biochim Biophys Acta 1985; 830:217-.
22. Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, et al. Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. Br J Cancer 1993;67:486-92.
23. Watanabe K, Naraki T, Yokoo T, Yamane S, Saitoh S, Okuda H, et al. Development of sensitive enzyme-immunoassay kit of PIVKA-II (ED 036) [in Japanese]. Rinshou to Kenkyu 1996;73:1476-81.
24. Takatsu K, Nakanishi T, Watanabe K, Okuda H, Hayashi N. Development of sensitive enzyme-immunoassay kit of PIVKA-II (ED 036). 2nd report. Evaluation of diagnostic ability. Rinshou to Kenkyu 1997;74:2137-41.
25. Saitoh S, Ikeda K, Koida I, Tsubota A, Arase Y, Chayama K, et al. Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas. Cancer 1994;74:2918-23.
26. Soga K, Arai F, Tsuruya T, Aikawa K, Toshima M, Shibasaki K, et al. Studies on factors affecting plasma PIVKA-II levels in hepatocellular carcinoma. Acta Med Biologica 1993;41:197-200.